CME
42
-4
HP
41
-4
XRX
52
-3
CL
58
2
ILMN
41
-3
VMC
57
-3
PEG
76
5
HBI
62
4
FAST
46
-3
VRTX
53
-2
IVZ
50
-3
CHD
54
6
UPS
55
-6
PG
51
3
AAP
24
-2
IBM
81
3
SHW
71
-2
VLO
40
-5
L
55
-4
FCX
53
-5
CME
42
-4
HP
41
-4
XRX
52
-3
CL
58
2
ILMN
41
-3
VMC
57
-3
PEG
76
5
HBI
62
4
FAST
46
-3
VRTX
53
-2
IVZ
50
-3
CHD
54
6
UPS
55
-6
PG
51
3
AAP
24
-2
IBM
81
3
SHW
71
-2
VLO
40
-5
L
55
-4
FCX
53
-5
Financhill
Back

The Hartford Financial Services Group Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
68

HIG
The Hartford Financial Services Group

Last Price:
116.31
Seasonality Move:
0.95%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
68
The Hartford Financial Services Group (HIG) is a Buy

Is The Hartford Financial Services Group a Buy, Sell or Hold?

  • The current The Hartford Financial Services Group [HIG] share price is $116.32. The Score for HIG is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • HIG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

HIG Stock Price Chart

What is The Hartford Financial Services Group's stock price today?

  • The The Hartford Financial Services Group share price today is $116.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIG is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

HIG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.74 Buy
Relative Strength Index (14 RSI): 61.1 Buy
Chaikin Money Flow: 2269752 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.44 - 116.66) Buy
Bollinger Bands (100): (99.43 - 111.63) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

HIG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 115.91 Buy
20-day SMA: 115.42 Buy
50-day SMA: 110.34 Buy
200-day SMA: 98.32 Buy
8-day EMA: 116.11 Buy
20-day EMA: 114.84 Buy
50-day EMA: 111.1 Buy
200-day EMA: 99.21 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

The Hartford Financial Services Group Earnings Growth & HIG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.33 per share, an increase this year of $1.84 per share, and an increase next year of $1.51 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

The Hartford Financial Services Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):